Prama Ghosh, Amity University Kolkata
After the recovery of President Donald Trump from Covid-19 using a similar therapy as of the antibody medicine from AstraZeneca Plc, the company has started its late-stage trials for the same against COVID-19.
The medicine will undergo two trials on more than 60000 people starting soon. Astra has also planned to test the medicine on 4000 adults as a treatment against the virus. Assessment of the drug on its ability to avoid infection for a year as well as its working as a pre-emptive medicine for people already affected will be noted.
Astra is exploring monoclonal antibodies as a treatment for people who may not respond well to a vaccine. The company has also agreed to supply as many as 100,000 doses to the U.S. by the end of the year 2020 with an option of purchasing one million additional doses in 2021, after receiving a large investment from the country. Previously, $25 million was given for the discovery and evaluation of the monoclonal antibodies to Astra and the phase I trial started in August. As claimed by The British Pharmaceutical company, the antibody medicine will provide immediate recovery from infection and shall have a long-lasting effect too.
Eli Lilly & Co. and Regeneron Pharmaceuticals Inc. had earlier pointed out that their medicines are effective in treating infective people outside hospitals. Advanced tests on antibody treatment were also started by GlaxoSmithKline Plc and Vir Biotechnology Inc. last week.
Also read: PEDIATRIC NEURODEVELOPMENT BY PRENATAL ZIKA VIRUS EXPOSURE
Suggest read: https://www.hindustantimes.com/world-news/astrazeneca-starts-late-stage-trials-of-covid-19-antibody-medicine/story-jTo7kLXZI3kZbWe9QbAK6O.html
- The Corrosion Prediction from the Corrosion Product Performance
- Nitrogen Resilience in Waterlogged Soybean plants
- Cell Senescence in Type II Diabetes: Therapeutic Potential
- Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
- AI Literacy in Early Childhood Education: Challenges and Opportunities
REVERBα (liver) gene - What about your midnight snack?
Arpita Adhikary, Amity University Kolkata Circadian rhythm is a 24-hour biological, natural rhythm that controls various regulatory internal mechanism including homeostasis, sleep-wake cycle etc. Different external (jet lag, night shift work, late-night eating) and internal factor (gene mutation, ageing, insomnia) are responsible for disruption of the circadian rhythm. Though rare disruption manages to keep the […]